| Prospects of molecular imaging. | |
| | |
MedLine Citation:
|
PMID: 22185949 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Modern radiotherapy techniques heavily rely on high-quality medical imaging. Increased accuracy to deliver the dose to tumours while sparing normal tissues demands more precise delineation of the tumours. When considering to deliver a boost to more aggressive parts of tumours, intratumoral heterogeneity needs to be assessed accurately. Adaptive radiotherapy demands evaluation of response during the course of radiotherapy, in terms of both volumetric and functional changes. Besides depicting anatomy, the role of functional and molecular imaging is therefore becoming increasingly important. Besides functional MRI, molecular imaging with positron emission tomography (PET) is rapidly evolving. PET provides biological information about the tumour, complementary to anatomical imaging. Integrated PET/computed tomography (CT) has already found its way into the practice of radiation oncology. For this purpose, [18F]fluorodeoxyglucose (FDG) is the most important radiopharmaceutical, e.g. in radiotherapy planning and follow-up. The PET-derived information augments accurate delineation of radiotherapy target volumes and treatment of the tumour and its extensions, while reducing the dose to surrounding healthy tissues. In addition to FDG, other PET tracers are available for imaging more specific biological tumour characteristics that play a pivotal role in radiation resistance. Using tracers that depict proliferation such as [18F]fluorthymidine or hypoxia such as 18F-labelled fluorinated imidazoles, the role of PET beyond FDG for patient selection, treatment modification and adaptation and early response monitoring are explored. |
| | |
Authors:
|
W J G Oyen |
Related Documents
:
|
7363549 - Distinction between obstructive and non-obstructive jaundice by sonography. 8735529 - Potential adverse effects of high-intensity focused ultrasound exposure on blood vessel... 19835299 - Ultrasound-based navigation and 3d ct compared in acetabular cup position. 1332399 - Ultrasound biomicroscopy in glaucoma. 7724149 - Localization of "lost" norplant capsules using compression film screen mammography. 22069759 - Role of the mannose receptor (cd206) in innate immunity to ricin toxin. 22287369 - Factors associated with computed tomography status in patients presenting with a histor... 1739599 - Magnetic resonance imaging contrast agents. 22477739 - Prenatal diagnosis and assessment of facial clefts: where are we now? |
Publication Detail:
|
Type: Journal Article Date: 2011-10-03 |
Journal Detail:
|
Title: Cancer imaging : the official publication of the International Cancer Imaging Society Volume: 11 ISSN: 1470-7330 ISO Abbreviation: Cancer Imaging Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-12-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101172931 Medline TA: Cancer Imaging Country: England |
Other Details:
|
Languages: eng Pagination: S154 Citation Subset: IM |
Affiliation:
|
Radboud University Nijmegen Medical Centre, Department of Nuclear Medicine, Nijmegen, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coprological survey of alimentary tract parasites in dogs from Zambia and evaluation of a coproantig...
Next Document: 2. The association between PET CT SUVmax values and patient mortality in primary oesophageal cancer.